Thrombin activatable fibrinolysis inhibitor in cancer patients with and without venous thromboembolism

Thromb Res. 2013 Oct;132(4):484-6. doi: 10.1016/j.thromres.2013.06.018. Epub 2013 Sep 9.

Authors

C M Radu¹, L Spiezia, E Campello, S Gavasso, B Woodhams, P Simioni

Affiliation

¹ Department of Cardiologic, Thoracic, and Vascular Sciences, 2nd Chair of Internal Medicine, University of Padua Medical School, Padua, Italy.

PMID: 24028756
DOI: 10.1016/j.thromres.2013.06.018

No abstract available

Publication types

Letter

MeSH terms

Aged
Carboxypeptidase B2 / blood*
Case-Control Studies
Female
Fibrinolysis
Humans
Male
Middle Aged
Neoplasms / blood*
Thrombin / metabolism
Thrombosis / blood
Venous Thromboembolism / blood*

Substances

Carboxypeptidase B2
Thrombin